Thirona’s RetCAD™ and iCare are joining forces in Europe to offer an integral solution for eye screening with artificial intelligence.

Nijmegen, the Netherlands April 27th, 2022 – Thirona, one of the leading companies specializing in artificial intelligence for medical image analysis, has signed a strategic partnership agreement with iCare, for the implementation of Thirona’s RetCAD™ artificial intelligence software into the iCare solutions for eye disease screening, in Europe. The partnership underpins both companies’ technological leadership in this field.

iCare is part of Revenio, a leading company in the global market for ophthalmological devices and software solutions. Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand. Icare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for diagnosis of glaucoma, diabetic retinopathy, and age-related macular degeneration (AMD).
”This is an exciting opportunity to contribute to keeping the wonderful world visible for all. Together with Thirona, we are implementing a top-performance screening solution based on fundus images. We start by screening diabetic retinopathy from diabetics and bring to market an integrated service that is fast and easy to use thanks to automation. High-quality images from the iCare DRSplus fundus imaging system provide a good foundation for the solution” says Pirjo Kortteisto, business development manager of Icare Finland.
Having every patient fundus examination instantly analyzed with a clinically validated software system, initial screening procedures can be done more efficiently and at least as accurate as when conducted by human experts. Simplified visualization of the examination analysis with heat maps supports eye care providers in validating the AI results and helps improve patient engagement in the prevention of severe eyesight problems and blindness.
“Combining high quality of iCare’s fundus images with RetCAD’s reliability of automated analysis, together we can provide eye care practitioners with a powerful trustworthy solution, enabling them screening more patients faster. Seamless integration of RetCAD™ into the iCare platform enables an optimal user experience, with test results instantly presented in a form of simple visualization, meaningful for the patient”, says Mark van Grinsven, head of Retina division at Thirona.
RetCAD™ is already distributed worldwide through integration partnerships with major fundus camera vendors such as Topcon, Canon, Tomey and Nidek, as well as medical solutions providers such as Delft Imaging. “By joining forces with iCare we can bring innovation to the mainstream markets faster. iCare is not just a distribution channel for us. Partnerships based on a shared vision and mutual trust are very centric to Thirona’s strategy, so we are happy to have iCare as our strategic partner”, says Diederik Sakkers, business development manager RetCAD at Thirona.


Share this article

More services


This article is featured in:


Comment on this article

You must be registered and logged in to leave a comment about this article.